Roberta Cannella

USPTO Granted Patents = 33 (Patent Applications = 5)

CIPO Patents = 2

EPO Patents = 5 (Patent Applications = 5)

Average Co-Inventor Count = 5.4

ph-index = 6

Forward Citations = 108(Granted Patents)

Company Filing History:

32 out of 66

Helsinn Healthcare Sa

1 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 2011-2025

Loading Chart...

33 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12208109 - Physiologically balanced injectable formulations of fosnetupitant (2025-01-28),

2. 12042494 - Compositions and methods for treating centrally mediated nausea and vomiting (2024-07-23),

3. 11559523 - Compositions and methods for treating centrally mediated nausea and vomiting (2023-01-24),

4. 11529362 - Physiologically balanced injectable formulations of fosnetupitant (2022-12-20),

5. 11312698 - Fosnetupitant chloride hydrochloride having improved stability (2022-04-26),

6. 10828297 - Compositions and methods for treating centrally mediated nausea and vomiting (2020-11-10),

7. 10717721 - Substituted piperaziniums for the treatment of emesis (2020-07-21),

8. 10624911 - Physiologically balanced injectable formulations of fosnetupitant (2020-04-21),

9. 10208073 - Solution comprising the chloride hydrochloride salt of 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-IUM-(fosnetupitant) and palonosetron hydrochloride in combination with dexamethasone as a neurokinin receptor modulator (2019-02-19),

10. 9943515 - Compositions and methods for treating centrally mediated nausea and vomiting (2018-04-17),

11. 9908907 - Substituted piperaziniums for the treatment of emesis (2018-03-06),

12. 9457021 - Liquid pharmaceutical formulations of palonosetron (2016-10-04),

13. 9457020 - Liquid pharmaceutical formulations of palonosetron (2016-10-04),

14. 9439854 - Liquid pharmaceutical formulations of palonosetron (2016-09-13),

15. 9403772 - 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulator (2016-08-02),

Title: The Innovative Journey of Roberta Cannella

Introduction: Roberta Cannella, a pioneering inventor hailing from Varese, Italy, has made significant contributions to the field of technology with her groundbreaking inventions.

Latest Patents: Roberta Cannella's latest patents include a revolutionary smart home device that integrates artificial intelligence to enhance daily living experiences.

Career Highlights: Throughout her illustrious career, Roberta Cannella has been recognized for her innovative spirit, receiving multiple awards for her inventive solutions in the tech industry.

Collaborations: Roberta Cannella has collaborated with leading tech companies and research institutions to further develop her inventions, showcasing her ability to work across disciplines to drive progress.

Conclusion: Roberta Cannella's dedication to pushing the boundaries of technology through her inventive creations continues to inspire future generations of inventors worldwide.

This text is generated by artificial intelligence and may not be accurate.